Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand flag Thailand · Delayed Price · Currency is THB
3.300
+0.020 (0.61%)
Last updated: Sep 8, 2026, 2:17 PM ICT

BKK:NAM Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6881,8701,1141,1011,100995.36
Revenue Growth
4.61%67.79%1.24%0.04%10.55%46.63%
Gross Profit
511.72540.57467.87480.05327.45340.63
Operating Income
107.55155.9212.33249.9224.06225.45
Net Income
81.33101.59180.87200.75175.71174.65
Earnings Per Share
0.120.150.260.336.688.73
EPS Growth
-54.82%-43.83%-20.90%-95.11%-23.46%56.17%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing and Distribution of Medical Equipment
1,0191,211628.42668.66590.65629.83
Manufacture and Distribute of Medical Supplies
370.94365.28303.88249.01296.42227.42
CSSD Sterilization Services, Medical Equipment Maintenance Services and Infectious Waste Services (SV)
310.6286.07176.03152.7--
Others
6.647.746.064.62--
Total
1,6881,8701,1141,101887.07857.25

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
687.8698.78980.781,099359.640.86
Total Debt
472.03495.31349.8231.35263.27374.89
Net Cash (Debt)
215.77203.47630.98867.2296.34-334.03
Net Cash Growth
-14.62%-67.75%-27.24%800.18%--
Net Cash Per Share
0.310.290.901.413.66-16.70

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
72.837.8622.94258.68-81.1693.61
Capital Expenditures
-35.06-42.79-55.57-30.41--
Free Cash Flow
37.74-4.94-32.64228.27-81.1693.61
Free Cash Flow Growth
149.39%-----10.60%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
30.31%28.91%41.98%43.61%29.76%34.22%
Operating Margin
6.37%8.34%19.05%22.70%20.36%22.65%
Pretax Margin
6.46%7.98%20.81%22.74%20.17%21.48%
Profit Margin
4.82%5.43%16.23%18.24%15.97%17.55%
FCF Margin
2.23%-0.26%-2.93%20.74%-7.38%9.40%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.1300.1300.1500.090
Dividend Per Share Growth
-13.33%-13.33%66.67%-
Dividend Yield
3.94%3.74%3.50%1.42%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
28.0624.1217.8024.23--
Forward PE
-13.7613.7617.38--
P/FCF Ratio
60.46--21.31--
PS Ratio
1.351.312.894.42--